Real|World Treatment Patterns

Real-world treatment patterns, comorbidities, and disease-related ...

MM treatment patterns have been dynamic over time. Comorbid conditions and myeloma-related complications increase as patients progress and may worsen MM ...

Real-world treatment patterns and outcomes in relapsed/refractory ...

The most common subsequent treatments were triplet combinations (41.6% of patients); daratumumab/pomalidomide/dexamethasone was the most common ...

Real-world treatment patterns, healthcare resource use and disease ...

To investigate treatment patterns, healthcare resource utilization and disease burden in patients with multiple myeloma (MM).

Real-world treatment patterns and overall survival among men with ...

More than 1 in 5 Medicare patients with mCRPC did not receive any life-prolonging therapy, and less than half received 2 L therapy.

Real-world treatment patterns and outcomes in patients with HR+ ...

This real-world study describes treatment patterns and outcomes in patients treated with chemotherapy in the United States before approval of antibody–drug ...

Real-World Treatment Patterns and Clinical Outcomes After ...

Patients with mNSCLC who had disease progression after anti–PD-(L)1/platinum-doublet chemotherapy had poor clinical outcomes with various treatment regimens.

Real-world treatment patterns and clinical outcomes with first-line ...

This was a retrospective observational study of real-world first-line treatment patterns and OS in patients with la/mUC stratified by cisplatin-eligibility and ...

Study to Describe the Real-world Treatment Patterns and ...

This multicountry, multicenter, retrospective, non-interventional study involving patients diagnosed with HER2-positive unresectable or metastatic breast ...

Real-world treatment patterns and outcomes of patients with ...

Patients with progressive mNSq NSCLC most commonly received later-line docetaxel for cancer without driver mutations, or platinum-based chemotherapy.

Real-world patient characteristics and treatment patterns in US ...

Patients from non-small cell lung cancer (NSCLC) controlled clinical trials do not always reflect real-world heterogeneous patient ...

Real-world treatment patterns and outcomes of patients with small ...

Current treatments utilized in the 3L-plus setting yield limited survival benefit. Furthermore, patients left untreated and placed on BSC typically live less ...

Recent real-world treatment patterns and outcomes in US patients ...

Median rwPFS (95% confidence interval [CI]) declined from 12.0 months (10.9, 13.4) at first-line to 2.9 months (2.3, 4.0) at fourth-line. Median ...

Real-world treatment patterns and sequencing in patients with ...

This RW study offers valuable insight into the characteristics of pts with la/mUC treated in routine clinical practice in the US.

Real-World Testing and Treatment Patterns Among Patients With ...

Real-World Testing and Treatment Patterns Among Patients With Stage IV NSCLC: A Retroscpective Observational Study.

Evaluating real-world treatment patterns and outcomes of mantle ...

We aimed to describe the treatment patterns in MCL at different lines of therapy with a focus on BTK inhibitor use and compare outcomes with known prognostic ...

P2.31-06 Real-World Treatment Patterns and Outcomes in Patients ...

Conclusions. This RW study describes the limited treatment options and quantifies the poor prognosis of patients with aNSCLC who are treated after prior ...

Treatment Patterns and Prescribing Practices Based on Real-World ...

Providing summary dashboards to clinicians gives them a quick overview of which regimens are being used to treat their target population. This information can ...

44P Real-world (RW) treatment patterns, patient characteristics and ...

This retrospective, observational, two-site cohort study included aNSCLC pts ≥18 years in age who initiated 1L systemic treatment for aNSCLC from 2017 to 2020.

P09.23 Real-World Treatment Patterns and Outcomes in Patients ...

In this real-world study, we assessed patient characteristics, treatment patterns, and overall survival (OS) in patients with NSCLC using Public Health ...

Real-world treatment patterns, healthcare resource utilization and ...

Real-world treatment patterns, healthcare resource utilization and costs of care among newly-diagnosed patients with HR+/HER2− metastatic ...